fda approved oral semaglutide Gets Approval for CV Event Reduction in High-risk Diabetes Patients FDA approves Novo Nordisk's oral

64 Mauro, G

However, they may be more likely to discontinue their ICI due to an irAE, or be at higher risk of an irAE specific to their condition (for example, colitis in a patient with a history of IBD)

It is an investigational drug

When Mounjaro activates these receptors, it stimulates insulin secretion when blood glucose is elevated, suppresses glucagon release (which normally raises blood sugar), and slows gastric emptying

This concern is not unfounded, as gastrointestinal side effects, including diarrhea, are often reported among those using this medication

The product arrived well packaged and in good condition, and the overall quality seems excellent